Nymox Pharm Corp (NYMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NYMX | AMGN | CELG | GILD | BIIB |
| Company | Nymox Pharm Corp | Amgen Inc | Celgene Corp | Gilead Sciences Inc | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.2200 | 269.93 | 108.01 | 68.27 | 198.73 |
| High | 0.2200 | 270.93 | 108.59 | 68.46 | 199.53 |
| Low | 0.1827 | 264.35 | 107.27 | 67.70 | 196.40 |
| Last | 0.2000 | 265.51 | 108.24 | 67.75 | 196.80 |
| Change | -0.0490 | -1.77 | +0.11 | -0.32 | -1.38 |
| % Change | -19.68% | -0.66% | +0.10% | -0.47% | -0.70% |
| Volume | 932,700 | 1,740,100 | 191,230,496 | 7,717,800 | 1,159,200 |
| 20-Day Average Volume | 309,280 | 2,348,660 | 16,188,930 | 6,525,295 | 1,116,865 |
| Previous Close | 0.2490 | 267.28 | 108.13 | 68.07 | 198.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3282 | 274.13 | 108.17 | 71.23 | 210.27 |
| 20-Day Raw Stochastic | 12.57% | 4.81% | 63.25% | 1.95% | 1.58% |
| 20-Day Relative Strength | 33.51% | 38.68% | 64.69% | 31.69% | 30.57% |
| Weighted Alpha | -62.47 | +5.78 | +46.30 | -22.75 | -35.90 |
| Today's Opinion | 56% Sell | 40% Sell | 100% Buy | 100% Sell | 100% Sell |
| Previous Opinion | 56% Sell | 40% Sell | 100% Buy | 100% Sell | 100% Sell |
| Last Month's Opinion | 32% Buy | 8% Sell | 100% Buy | 40% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -28.98% since 06/28/23 | -1.37% since 04/08/24 | -1.97% since 11/13/19 | -2.41% since 04/08/24 | -3.98% since 04/08/24 |
| Low | 0.1688 on 06/30/23 | 264.35 on 04/15/24 | 107.27 on 11/20/19 | 67.62 on 04/12/24 | 196.40 on 04/15/24 |
| High | 0.3500 on 07/03/23 | 273.00 on 04/11/24 | 110.53 on 11/14/19 | 69.95 on 04/09/24 | 209.06 on 04/09/24 |
| 1-Month | |||||
| %Chg | -50.94% since 06/06/23 | -1.25% since 03/15/24 | +5.14% since 10/18/19 | -8.06% since 03/15/24 | -10.26% since 03/15/24 |
| Low | 0.1688 on 06/30/23 | 264.35 on 04/15/24 | 102.40 on 10/21/19 | 67.62 on 04/12/24 | 196.40 on 04/15/24 |
| High | 0.4170 on 06/16/23 | 288.57 on 03/28/24 | 110.70 on 11/13/19 | 74.28 on 03/21/24 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | -43.80% since 04/06/23 | -13.38% since 01/12/24 | +13.63% since 08/20/19 | -21.57% since 01/12/24 | -20.68% since 01/12/24 |
| Low | 0.1688 on 06/30/23 | 264.35 on 04/15/24 | 93.41 on 08/23/19 | 67.62 on 04/12/24 | 196.40 on 04/15/24 |
| High | 0.4950 on 05/08/23 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 87.86 on 01/19/24 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | -50.73% since 01/06/23 | -6.54% since 10/13/23 | +14.14% since 05/20/19 | -12.75% since 10/13/23 | -24.96% since 10/13/23 |
| Low | 0.1688 on 06/30/23 | 249.70 on 10/31/23 | 89.08 on 07/23/19 | 67.62 on 04/12/24 | 196.40 on 04/15/24 |
| High | 0.5299 on 02/16/23 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 87.86 on 01/19/24 | 269.43 on 10/17/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,103 | 143,240,432 | 77,035,920 | 84,752,392 | 28,807,640 |
| Shares Outstanding, K | 90,515 | 535,919 | 711,714 | 1,245,077 | 145,361 |
| Annual Sales | 0 | 28,190,000,000 | 15,281,000,000 | 27,116,000,000 | 9,835,600,000 |
| Annual Net Income | -6,580,000 | 6,717,000,000 | 4,046,000,000 | 5,665,000,000 | 1,161,100,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 4,520,000,000 | 7,114,000,000 | 2,386,300,000 |
| Last Quarter Net Income | -1,390,000 | 767,000,000 | 1,691,000,000 | 1,429,000,000 | 249,700,000 |
| 60-Month Beta | 0.64 | 0.58 | 1.41 | 0.19 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 05/12/23 | 4.71 on 02/06/24 | 2.99 on 10/31/19 | 1.72 on 02/06/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 08/21/23 | 05/02/24 | 10/31/19 | 04/25/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.33 | 10.99 | 10.13 | 13.45 |